Day 1 - Thursday, 19 October 2017
Meeting category
Date(s)
19 Oct 2017 - 20 Oct 2017
Location
Rockville,
United States
Organizer
Platinum Level Support
Sponsor logos
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Related Enduring Materials
Enduring Materials
-
Opening Lecture: Brain-Gut-Microbiota interactions and intestinal health
Session 1: Pathogenesis -
Chairs
Cara Wilson, MD
University of Colorado, United States
Sandra Pinto Cardoso, PhD
National Institute of Respiratory Diseases (INER), Mexico
Mining adaptive immunity to identify disease-promoting microbiota members in HIV
Ivan Vujkovic-Cvijin, PhD
National Institutes of Health, Mucosal Immunology Section, USA
Microbial colonization of the gut and brain development in infancy
Differential responses of colonic ILCs to gut commensal bacteria altered during HIV infection
Microbial dysbiosis does not alter immune activation or disease progression in SIV-infected rhesus macaques
Session 2: Transmission & Prevention -
Chairs
Piotr Nowak, MD, PhD
Karolinska University Hospital, Sweden
Laurel Lagenaur PhD
NIH, United States
Microbe: drug interactions and the impact on HIV infection and pathogenesis
Cervicovaginal microbial dynamics and its impact on HIV acquisition risk
Vaginal lactic acid inhibits production of pro-inflammatory mediators from human cervicovaginal epithelial cells associated with HIV acquisition
Session 3: GI Tract and Diet -
Chairs
Satya Dandekar, PhD
University of California, Davis, United States
Nichole Klatt , PhD
University of Minnesota, United States
Detrimental impact of a high fat diet on the natural history of SIV infection in non-human
Ivona Pandrea, MD, PhD
University of Pittsburgh, USA
Milk - guiding the infant microbiome
Understanding complexities of gut microbiome dysbiosis in HIV infected populations using a large cohor
Plasma tryptophan-kynurenine metabolites are altered with gut microbiota dysbiosis in HIV infection and associated with progression of carotid artery atherosclerosis
DAY 2 - Friday, 20 October 2017
Session 4: Comorbidities -
Chairs
Ronald Collman, MD
NIH, United States
Alan Landay, PhD
Rush University Medical Center, United States
Inflammatory bowel disease (IBD) and colon cancer and microbiome
William DePaolo, PhD
University of Washington, USA
Microbial metabolites in HIV pathogenesis and comorbidities
Dana Gabuzda, MD
Harvard Medical School, USA
Composite analysis of bacteriome and virome from HIV/HPV-coinfected pregnant women reveals proxies for intraepithelial lesions and immunodeficiency status
Marcelo Soares, Brazil
Abstract #: O_05
Session 5: Microbiome & Vaccines -
Chairs
Que Dang, PhD
NIAID/NIH, USA
Angela Malaspina, PhD
NIAID/NIH, USA
Aging, the microbiome and vaccine responses
Daria Hazuda, PhD
Merck, USA
Mechanisms intersecting microbiota metabolomics with gut epithelial barrier repair in HIV infection
Role of the microbiome in HIV vaccine response heterogeneity
Effect of high-risk sexual behaviouron diversity of the vaginal microbiota and abundance of lactobacillus
Session 6: Metabolomics Biologic and Technical issues -
Chairs
Frederic Bushman, PhD
University of Pennsylvania, United States
Roger Paredes, MD, PhD
IrsiCaixa AIDS Research Institute, Badalona, Catalonia, Spain
Studying the functional microbiome in vivo in HIV by metaproteomics approaches
Fatty acid profiles differ in HIV infection, persist despite suppressive ART, and are associated with immune activation
Nicholas Funderburg, PhD
Ohio State University College of Medicine USA
Modulation of gut microbiota by indoleamine 2,3-dioxygenase 1 inhibitor during antiretroviral suppressed SIV infection in rhesus macaques
The microbial-derived short chain fatty acid butyrate directly and differentially inhibits gut T helper cell subset activation and proliferation
Overview
Welcome
We are pleased to look back on a very successful 3rd International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment, held from 19 - 20 October 2017 in Rockville, Maryland, USA.
The Organizing Committee and organizers would like to thank the speakers, chairs and all participants for their contribution to this meeting! Special thanks to the workshop sponsors: ViiV Healthcare, Mylan, Merck, and Just Thrive Probiotic. Without their financial contribution this workshop would not have been made possible.
The Organizing Committee
General Information
Unique Features
The meeting features for the workshop are to its multidisciplinary nature and significance in enabling to learn how the host microbiome can influence responses to our current HIV therapies, and to further our ability to develop novel prevention and therapeutic strategies for HIV that will lead to the reduction of new HIV infections and the burden of non-communicable diseases in HIV infected subjects.
Meeting Objectives
This meeting aims to:
- To gather cross-disciplinary professionals in the field of microbiome research to provide a better understanding of the impact of microbiome changes on HIV outcomes
- To develop a better understanding of how the microbiome effects the pathogenesis of HIV across mucosal sites
- To enhance our knowledge of how the microbiome can impact vaccine responses
- To better understand how the microbiome can contribute to the development of non-communicable diseases
- To use our knowledge of the microbiome field in developing novel strategies for developing microbicides for HIV prevention
- To bring together scientists from across the globe to enhance our understanding of how we can use approaches to modulate the microbiome to reduce levels of inflammation
- To bring together bioinformatics experts in enhancing our ability to analyze complex data generated by sequencing the host microbiome
- To gather cross-disciplinary professionals in the field of microbiome research to provide a better understanding of the impact of microbiome changes on HIV outcomes
- To develop a better understanding of how the microbiome effects the pathogenesis of HIV across mucosal sites
- To enhance our knowledge of how the microbiome can impact vaccine responses
- To better understand how the microbiome can contribute to the development of non-communicable diseases
- To use our knowledge of the microbiome field in developing novel strategies for developing microbicides for HIV prevention
- To bring together scientists from across the globe to enhance our understanding of how we can use approaches to modulate the microbiome to reduce levels of inflammation
- To bring together bioinformatics experts in enhancing our ability to analyze complex data generated by sequencing the host microbiome
Learning Objectives
After participating in this activity, participants will be able to:
- Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium
- Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium
- Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium
- Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium
- Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium
- Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium
Practical Information
Language
The official language of the workshop was English
No simultaneous translation was provided.
No simultaneous translation was provided.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the workshop participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Support
Language
Related Programs
